Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Aggen DH, Chu CE, Rosenberg JE

Publication

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication ID (Profile URL)

https://researcherprofiles.org/profile/428419518

Publication Year

2023

PubMed ID

36749325

Publication Title

Aggen DH, Chu CE, Rosenberg JE. Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance. Clin Cancer Res. 2023 04 14; 29(8):1377-1380.